“I am very honored to be appointed to chair the Academy,” said Kimmel. “My goals are to uphold the high standards that ACRP has set for its examinations, and to maintain the exam products as the gold standard for certification in the clinical research enterprise.”
As the administrative entity for ACRP certification programs, the Academy Board of Trustees supervises exam committees, reviews test results and manages vendors that are used to help produce exams. The Board of Trustees is responsible for both US and international exams.
“We are extremely proud of Kathryn’s accomplishments, and this appointment is testament to her leadership ability and industry commitment,” said Jeff Page, Executive Director, Business Excellence and Field Operations, at Clinsys. “Her continued involvement with ACRP reflects her dedication to ensuring clinical research quality through certification, a standard that Clinsys holds in high regard.”
Kimmel began her career in clinical research as a CRC in 1994. She was a founding member of ACRP’s former Inland Northwest Chapter and served as president for three years. Kimmel has maintained her standing as a Certified CRC since 1998 and as a Certified CRA since 2003. She also previously served on ACRP’s CRC Examination Committee for eight years, including six years as chair, and has been a coeditor of Home Study tests for ACRP’s peer-reviewed journal, The Monitor, since 2004.
About Clinsys Clinical Research, Inc. Clinsys Clinical Research, Inc.®, is a therapeutically focused global contract research organization that provides pharmaceutical, biotechnology and medical device companies with a full range of clinical research services in support of Phase I-IV drug and device development. Clinsys has expertise in highly specialized therapeutic areas, including oncology, central nervous system, dermatology, respiratory and cardiovascular. To ensure all projects are completed successfully and efficiently, Clinsys employs its Global Program Solutions™, which integrate its Global Project Solution® (Clinsys GPS®) methodology with Therapeutically Aligned Program Strategists™ (Clinsys TPS™) team capabilities.
Clinsys is a Jubilant Organosys company headquartered in Bedminster, New Jersey, with operations in Raleigh, North Carolina; Philadelphia, Pennsylvania; Ottawa, Canada; and Düsseldorf, Germany. Clinsys Clinical Research, Ltd., with offices in Noida and Bangalore, India, provides extensive clinical research services for Phase I-IV drug development, and operates a clinical pharmacology unit performing bioavailability and bioequivalence studies as well as bioanalytical sample analysis, clinical laboratory and pathology services. Clinsys ALTERNA®, a division of Clinsys Clinical Research, Inc., partners with clients globally to provide customized Phase I-IV clinical trial alternative solutions to the conventional outsourcing model. For more information, visit clinsys.com.
Contact Mitchell Winfree Vice President, Global Business Development and Marketing Clinsys Clinical Research, Inc. 919.889.2992 mwinfree@clinsys.com
